Actavis Acquires Botox Maker Allergan Pharmaceuticals

Actavis Acquires Botox Maker Allergan Pharmaceuticals

November 19, 2014
By Beverly Brooks
The Plastic Surgery Channel

Some changes are in the works for Botox® maker Allergan. Botox, the gold standard for non surgical removal of frown lines, will now be run by pharmaceutical giant Actavis, in what’s perceived as a positive move by many board certified plastic surgeons.

wp2“Despite market trends and shareholder demands, Allergan has remained focused on research and development,” says Caroline Glicksman, MD, a board certified plastic surgeon in New Jersey. “It is my sincere hope that their commitment to our patients through medical innovation continues after the acquisition by Actavis.”

Allergan Dodges Hostile Takeover by Valeant

Allergan dodged a hostile takeover by another pharma company Valeant Pharmaceuticals, Inc., with a recent offer valued at $54 billion.

Hundreds of letters from the medical community expressed concern about Valeant Pharmaceuticals.  The disagreement revolved around fears that Valeant would sharply cut Allergan’s funding in research-and-development.

“Research, development, and clinical education have always been very important for Allergan, which is why the Valeant hostile bid was disconcerting,” says Pat McGuire, MD, a board certified plastic surgeon in St. Louis.

SONY DSCWill Actavis Support Botox® and Research?

“Actavis seems to have a similar philosophy to Allergan, with a strong commitment to research and development, so this appears to be a positive merger,” says Dr. Pat McGuire.

“I work for an innovative company — that’s why I’m working for Allergan,” says Philippe Schaison, President of U.S. Medical for Allergan, “I’m all about science, and we have the duty to bring innovation to patients and physicians.”

While Botox is a game changer when it comes to eliminating frown lines, Allergan has also captured a huge market share with the recent introduction of JUVÉDERM VOLUMA® XC to the United States. Voluma is the first and only FDA-approved injectable gel to instantly add volume to the cheek area and give the face a subtle lift for up to two years.

Allergan also recently launched SERI Surgical Scaffold, a bio-degradable material used in procedures requiring tissue support in the breast and abdomen.

The recent acquisition is perceived as a win-win in many medical circles because it positions Actavis as a top ten global pharmaceutical company, with more than a dozen medical advances already in the ‘pipeline’ or development stage.

Click to add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

More in

Tummy tuck - the abdominal fixer-upper.

Tummy Tuck – The Abdominal Fixer-Upper

Shaun Parson, MDAugust 18, 2017
Chest Surgery for Transgender Patients

Top Surgery for Transgender Patients

Patricia McGuire, MDAugust 17, 2017
The limits of plastic surgery.

The Limits of Plastic Surgery

Ned Snyder IV, MDAugust 16, 2017
Headline News - Did Kylie Jenner Get Implants?!

Headline News – Did Kylie Jenner Get Implants?!

Jason Pozner, MDAugust 15, 2017
Avoid the injectables lottery.

Avoid the Injectables Lottery

Craig ColvilleAugust 15, 2017
CoolSculpting: No Fat with No Surgery

CoolSculpting: No Fat with No Surgery

Steven CampAugust 14, 2017
The Silhouette Lift - A non-surgical facelift alternative.

The Silhouette Lift – A Non-Surgical Facelift Alternative

Christine Hamori, MDAugust 11, 2017
In the right hands, injectables can go far.

In The Right Hands, Injectables Can Go Far

Mark A. Pinsky, MDAugust 10, 2017
Patients are digging the drainless tummy tuck.

Patients Are Digging the Drainless Tummy Tuck

Ned Snyder IV, MDAugust 9, 2017